Further, ezrin was implicated as an EMT regulator and tumor promoter in cervical cancer, and downregulation of ezrin suppressed cervical cancer progression, possibly via the phosphoinositide 3-kinase/Akt pathway (25). Here, AKT1 is linked to cervical carcinoma.